Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 2
2004 5
2005 2
2006 5
2008 1
2010 2
2011 6
2012 2
2013 2
2015 1
2016 5
2017 2
2018 2
2019 5
2020 2
2022 2
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

43 results

Results by year

Filters applied: . Clear all
Page 1
Ustekinumab as Induction and Maintenance Therapy for Ulcerative Colitis.
Sands BE, Sandborn WJ, Panaccione R, O'Brien CD, Zhang H, Johanns J, Adedokun OJ, Li K, Peyrin-Biroulet L, Van Assche G, Danese S, Targan S, Abreu MT, Hisamatsu T, Szapary P, Marano C; UNIFI Study Group. Sands BE, et al. N Engl J Med. 2019 Sep 26;381(13):1201-1214. doi: 10.1056/NEJMoa1900750. N Engl J Med. 2019. PMID: 31553833 Free article. Clinical Trial.
I-CARE, a European Prospective Cohort Study Assessing Safety and Effectiveness of Biologics in Inflammatory Bowel Disease.
Peyrin-Biroulet L, Rahier JF, Kirchgesner J, Abitbol V, Shaji S, Armuzzi A, Karmiris K, Gisbert JP, Bossuyt P, Helwig U, Burisch J, Yanai H, Doherty GA, Magro F, Molnar T, Löwenberg M, Halfvarson J, Zagorowicz E, Rousseau H, Baumann C, Baert F, Beaugerie L; I-CARE Collaborator Group. Peyrin-Biroulet L, et al. Clin Gastroenterol Hepatol. 2023 Mar;21(3):771-788.e10. doi: 10.1016/j.cgh.2022.09.018. Epub 2022 Sep 22. Clin Gastroenterol Hepatol. 2023. PMID: 36152897 Free article.
Aktualisierte S3-Leitlinie Colitis ulcerosa – Living Guideline.
Kucharzik T, Dignass AU, Atreya R, Bokemeyer B, Esters P, Herrlinger K, Kannengießer K, Kienle P, Langhorst J, Lügering A, Schreiber S, Stallmach A, Stein J, Sturm A, Teich N, Siegmund B; Collaborators:. Kucharzik T, et al. Among authors: lugering a. Z Gastroenterol. 2020 Dec;58(12):e241-e326. doi: 10.1055/a-1296-3444. Epub 2020 Dec 1. Z Gastroenterol. 2020. PMID: 33260237 German. No abstract available.
[August 2019 - AWMF-Registriernummer: 021-009].
Kucharzik T, Dignass AU, Atreya R, Bokemeyer B, Esters P, Herrlinger K, Kannengießer K, Kienle P, Langhorst J, Lügering A, Schreiber S, Stallmach A, Stein J, Sturm A, Teich N, Siegmund B; Collaborators:. Kucharzik T, et al. Among authors: lugering a. Z Gastroenterol. 2019 Nov;57(11):1321-1405. doi: 10.1055/a-1015-7265. Epub 2019 Nov 18. Z Gastroenterol. 2019. PMID: 31739378 German. No abstract available.
[August 2019 - AWMF-Registriernummer: 021-009].
Kucharzik T, Dignass AU, Atreya R, Bokemeyer B, Esters P, Herrlinger K, Kannengießer K, Kienle P, Langhorst J, Lügering A, Schreiber S, Stallmach A, Stein J, Sturm A, Teich N, Siegmund B; Collaborators:. Kucharzik T, et al. Among authors: lugering a. Z Gastroenterol. 2019 Nov;57(11):e1. doi: 10.1055/a-1108-3778. Epub 2020 Feb 18. Z Gastroenterol. 2019. PMID: 32069500 German. No abstract available.
Apoptosis as a therapeutic tool in IBD?
Lügering A, Lebiedz P, Koch S, Kucharzik T. Lügering A, et al. Ann N Y Acad Sci. 2006 Aug;1072:62-77. doi: 10.1196/annals.1326.013. Ann N Y Acad Sci. 2006. PMID: 17057191 Review.
43 results